|
 Role of PPARs in the Treatment of Insulin Resistance & Cardiovascular Disease
Faculty: Lawrence Blonde, MD, FACP, FACE | James R Gavin III, MD, PhD
CME Credit hour: 1.0
This CME initiative provides primary care providers, endocrinologists and cardiologists, who are the forefront in preventing and treating diabetes and CVD, with up-to-date information on the role of PPARs in the treatment of insulin-resistant diabetes and CVD. Topics of discussion include the interrelationship and impact of diabetes, metabolic syndrome, and CVD; current treatment strategies and unmet needs; safety and efficacy data on PPAR activators; and the potential clinical application of dual alpha-gamma PPAR activators.
|
